Translate Bio Appoints George Demetri, M.D., to its Board of Directors

NEXT STORY
Advanced Wound Dressings Market to Reach US$ 8,460.8 Mn by 2025, Increasing FDA Approvals to Enable Growth, says Fortune Business Insights
PREV STORY
RedHill Biopharma to Host Second Quarter 2019 Financial Results Conference Call on July 23, 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Melinta Therapeutics Announces U.S. FDA Approval of Baxdela™ (Delafloxacin) for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

- Baxdela offers a new option for treatment of adult patients with acute bacterial ...

author_avatar
NASDAQ Market News

FDA Clears Sorrento Phase 2 Trial Of Non-Opioid Product Candidate Resiniferatoxin (RTX) For Treatment of the Knee Pain in Osteoarthritis (OA) Patients

author_avatar
NASDAQ Market News

Konferensi Dunia Kanker Paru-Paru Ke-19 IASLC Digelar di Toronto, Kanada

DENVER, Aug. 22, 2018 (GLOBE NEWSWIRE) -- Apa: Asosiasi Internasional untuk Studi Kanker Paru-Paru (The ...

author_avatar
NASDAQ Market News